title: Liver transplantation for alcoholic liver disease.
abstract: Orthotopic liver transplantation (OLT) for individuals with alcoholic liver disease (ALD) remains controversial. This review was designed to evaluate the survival, recidivism, and rehabilitation of the alcoholic liver transplant recipient in a single transplant center.
  
  
  METHODS
  Between 10/86 and 11/92 203 liver transplants were performed in 179 patients. In 42 patients (23%) the primary etiologic diagnosis was ALD (36 males, 6 females, median age 47 yr). All ALD patients were evaluated preoperatively by social service, psychiatry, and medical psychology, in addition to hepatology and transplant surgery. A minimum abstinence period of 3-6 months was encouraged, although exceptions were made for cases of extreme medical urgency in which a good prognosis for abstinence was predicted.
  
  
  RESULTS
  In OLT recipients with ALD, actuarial survival at 1, 2, and 3 yr was 74%, 71%, and 71%, respectively, compared to 71%, 71%, and 69% for all OLT recipients. One- and two-year survival was 85% in the most recently transplanted 86 patients, 20 of whom (23%) had ALD with 1- and 2-yr survival of 84% (N.S.). Recidivism was monitored postoperatively by interviews with the patient and family, supplemented by random urine and serum toxicology. Of the 29 survivors, 2 (7%) returned temporarily to alcohol use but are presently abstinent. Although none of the ALD patients in this study was able to work prior to OLT, 76% of the survivors at least 4 months post-transplantation were employed.
  
  
  CONCLUSIONS
  Although our experience is small, our results suggest that OLT is appropriate therapy for carefully selected patients with end-stage liver failure due to ALD. The multi-disciplinary approach to preoperative evaluation of the alcoholic liver transplant candidate is effective in determining those patients committed to abstinence after a successful transplant.
authors.affiliation: Department of Surgery, Louisiana State University Medical Center, Shreveport 71130-3932, USA.
authors.forename: G B
authors.initials: GB
authors.lastname: Zibari
authors.forename: D
authors.initials: D
authors.lastname: Edwin
authors.forename: L
authors.initials: L
authors.lastname: Wall
authors.forename: A
authors.initials: A
authors.lastname: Diehl
authors.forename: J
authors.initials: J
authors.lastname: Fair
authors.forename: J
authors.initials: J
authors.lastname: Burdick
authors.forename: A
authors.initials: A
authors.lastname: Klein
mesh_terms: D000206:Actuarial Analysis; D000328:Adult; D000368:Aged; D004651:Employment; D005260:Female; D006801:Humans; D008108:Liver Diseases, Alcoholic / Q000534:rehabilitation / Q000601:surgery*; D016031:Liver Transplantation / Q000401:mortality; D008297:Male; D008875:Middle Aged; D010348:Patient Care Team; D018579:Patient Selection; D011300:Preoperative Care; D012008:Recurrence; D016019:Survival Analysis